Abstract
Cell therapy is a major discipline of regenerative medicine that has been continually growing over the last two decades. The aging of the population necessitates discovery of therapeutic innovations to combat debilitating disorders, such as stroke. Menstrual blood and Sertoli cells are two gender-specific sources of viable transplantable cells for stroke therapy. The use of autologous cells for the subacute phase of stroke offers practical clinical application. Menstrual blood cells are readily available, display proliferative capacity, pluripotency and angiogenic features, and, following transplantation in stroke models, have the ability to migrate to the infarct site, regulate the inflammatory response, secrete neurotrophic factors, and have the possibility to differentiate into neural lineage. Similarly, the testis-derived Sertoli cells secrete many growth and trophic factors, are highly immunosuppressive, and exert neuroprotective effects in animal models of neurological disorders. We highlight the practicality of experimental and clinical application of menstrual blood cells and Sertoli cells to treat stroke, from cell isolation and cryopreservation to administration.
Keywords: Menstrual blood, Sertoli cells, autologous, ischemic stroke, regenerative.
CNS & Neurological Disorders - Drug Targets
Title:The Battle of the Sexes for Stroke Therapy: Female- Versus Male-Derived Stem Cells
Volume: 12 Issue: 3
Author(s): Yuji Kaneko, Mibel M. Pabon, Travis Dailey, Nathan L. Weinbren, Jessica Rizzi, Cyrus Tamboli, Julianne Vasconcellos, Nicole Kuzmin-Nichols, Paul R. Sanberg, David J. Eve, Naoki Tajiri and Cesar V. Borlongan
Affiliation:
Keywords: Menstrual blood, Sertoli cells, autologous, ischemic stroke, regenerative.
Abstract: Cell therapy is a major discipline of regenerative medicine that has been continually growing over the last two decades. The aging of the population necessitates discovery of therapeutic innovations to combat debilitating disorders, such as stroke. Menstrual blood and Sertoli cells are two gender-specific sources of viable transplantable cells for stroke therapy. The use of autologous cells for the subacute phase of stroke offers practical clinical application. Menstrual blood cells are readily available, display proliferative capacity, pluripotency and angiogenic features, and, following transplantation in stroke models, have the ability to migrate to the infarct site, regulate the inflammatory response, secrete neurotrophic factors, and have the possibility to differentiate into neural lineage. Similarly, the testis-derived Sertoli cells secrete many growth and trophic factors, are highly immunosuppressive, and exert neuroprotective effects in animal models of neurological disorders. We highlight the practicality of experimental and clinical application of menstrual blood cells and Sertoli cells to treat stroke, from cell isolation and cryopreservation to administration.
Export Options
About this article
Cite this article as:
Kaneko Yuji, Pabon Mibel M., Dailey Travis, Weinbren Nathan L., Rizzi Jessica, Tamboli Cyrus, Vasconcellos Julianne, Kuzmin-Nichols Nicole, Sanberg Paul R., Eve David J., Tajiri Naoki and Borlongan Cesar V., The Battle of the Sexes for Stroke Therapy: Female- Versus Male-Derived Stem Cells, CNS & Neurological Disorders - Drug Targets 2013; 12 (3) . https://dx.doi.org/10.2174/1871527311312030013
DOI https://dx.doi.org/10.2174/1871527311312030013 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nature and Nurture in the Early-Life Origins of Metabolic Syndrome
Current Pharmaceutical Biotechnology Targeted Delivery of Bleomycin: A Comprehensive Anticancer Review
Current Cancer Drug Targets Recent Inventions on Receptor Tyrosine Kinase RET Modulation
Recent Patents on Biotechnology Cancer: A Problem of Developmental Biology; Scientific Evidence for Reprogramming and Differentiation Therapy
Current Drug Targets Subject Index to Volume 10
Current Pharmaceutical Design Biological and Chemical Aspects of Natural Biflavonoids from Plants: A Brief Review
Mini-Reviews in Medicinal Chemistry Analytical Approaches for Assaying Metallodrugs in Biological Samples: Recent Methodological Developments and Future Trends
Current Drug Metabolism Gene Electrotransfer: A Mechanistic Perspective
Current Gene Therapy The Effects of the Endocrine Disruptors Dithiocarbamates on the Mammalian Ovary with Particular Regard to Mancozeb
Current Pharmaceutical Design Modelling DNA Repair Pathways: Recent Advances and Future Directions
Current Pharmaceutical Design Recent Progress of Novel Steroid Derivatives and Their Potential Biological Properties
Mini-Reviews in Medicinal Chemistry Prophylaxis with Bacopa monnieri Attenuates Acrylamide Induced Neurotoxicity and Oxidative Damage via Elevated Antioxidant Function
Central Nervous System Agents in Medicinal Chemistry Metallothioneins and Cancer
Current Protein & Peptide Science Mechanisms of Male Infertility: Role of Antioxidants
Current Drug Metabolism Interplay between DNA Methyltransferase 1 and microRNAs During Tumorigenesis
Current Drug Targets Genitourinary Tumors: Update on Molecular Biomarkers for Diagnosis, Prognosis and Prediction of Response to Therapy
Current Drug Metabolism Repurposing of Anticancer Drugs for the Treatment of Bacterial Infections
Current Topics in Medicinal Chemistry Antiviral Treatment of Cytomegalovirus Infection
Infectious Disorders - Drug Targets Understanding the Concept of Chronotherapeutics in the Management of Diabetes Mellitus
Current Diabetes Reviews Membrane Fusion Mediated Targeted Cytosolic Drug Delivery Through scFv Engineered Sendai Viral Envelopes
Current Molecular Medicine